JPMorgan Starts Savient (SVNT) at Overweight Dec 4, 2009 07:30AM

JPMorgan initites coverage on Savient (Nasdaq: SVNT) ...


Savient Pharma (SVNT) Closes 4.95M Share Public Offering Oct 15, 2009 11:26AM

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised in full their option to purchase an additional 645,000 shares of common stock. As a result ...


Unusual 11 Mid-Day Movers 10/08: CLWT, LIZ, XRM, NCT Higher; RPRX, STC, SVNT, TLR Lower Oct 8, 2009 01:01PM

Euro Tech Holdings Co. Ltd. (Nasdaq: CLWT) 33.9% HIGHER; not hearing any company-specific news today that would justify today's move. The stock is trading on extremely heavy volume.

Repros Therapeutics (Nasdaq: RPRX) 23.7% LOWER; today announced that Repros has entered into a definitive agreement with institutional investors to sell 3.5 million shares of its common stock at $1.27 per share for gross proceeds of approximately $4.4 million. The offering is expected to close on or about October 9, 2009, subject to the satisfaction of customary closing conditions.

Liz ...


Morning Movers 10/08: RPC, NCT, TLF, LIZ, DDSS Higher; CTZN, RPRX, STC, TLR, VG, SVNT Lower Oct 8, 2009 10:26AM

Citizens First Bancorp, Inc. (Nasdaq: CTZN) 21% LOWER; an Audit Committee for the company's Board determined that there was a material impairment of Citizens First Bancorp, Inc.’s loans and collateralized loan obligations that was not reported in the Company’s June 30, 2009 Form 10-Q.

Repros Therapeutics (Nasdaq: RPRX) 20.4% LOWER; today announced that Repros has entered into a definitive agreement with institutional investors to sell 3.5 million shares of its common stock at $1.27 per share for gross proceeds of approximately $4.4 million. The offering is expected to close on or about October 9, 2009, subject to the satisfaction of customary closing conditions.

Radient Pharmaceuticals Corporation (Amex: RPC) 16.7% HIGHER; announced today it has entered into an exclusive 5-year marketing and distribution agreement with Grifols USA, LLC. Under the terms of the agreement, Grifols USA, LLC will market and sell ADI's DR-70 Onko-Sure cancer test for the monitoring ...


After-Hours Movers 10/07: SCSC, HOTT, TGIC, AA, CPKI Higher; LXRX, SVNT Lower Oct 7, 2009 05:54PM

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) 10.8% LOWER; today announced that it is offering to sell, subject to market and other conditions, 27,500,000 shares of its common stock pursuant to an effective shelf registration statement, of which 16,412,613 shares are being offered through the underwriters and 11,087,387 shares are being offered to Invus, L.P., Lexicon's largest stockholder. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an aggregate of 2,461,892 additional shares of common stock to cover over-allotments, if any.

ScanSource, Inc. (NASDAQ: SCSC) 7.3% HIGHER; sees first quarter revenues in a range of $480 million to $488 million, versus prior guidance of ...




Oct 7, 2009 04:03PM Savient Pharma (SVNT) to Sell 4M Shares in Public Offering
Aug 3, 2009 09:41AM Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower
Jun 12, 2009 12:35PM Unusual 11 Mid-Day Movers 6/12: SVNT, APPY, WH, ETFC Higher; HOKU, CBT, EZPW, STAA Lower